A Phase II Comparative Study of Gross Tumor Volume Definition With or Without PET/CT Fusion in Dosimetric Planning for Non–Small-Cell Lung Cancer (NSCLC): Primary Analysis of Radiation Therapy Oncology Group (RTOG) 0515
Authors:
- 1 January 2012
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 82 (1) , 435-441.e1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Use of PET and PET/CT for Radiation Therapy Planning: IAEA expert report 2006–2007Radiotherapy and Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- The Effect of FDG-PET on the Stage Distribution of Non-small Cell Lung CancerJournal of Thoracic Oncology, 2008
- Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectivesRadiotherapy and Oncology, 2006
- Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- AJCC Cancer Staging Manual2002
- The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancerRadiotherapy and Oncology, 2000
- 18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospectsLung Cancer, 1999
- The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Lung Cancer, 1998